Somatic Genetic Testing Market Growth Through 2030 Creates New Strategic Opportunities
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Somatic Genetic Testing Market Size, Value And Growth Trends Through 2030
The somatic genetic testing market has experienced swift expansion in recent years, with projections indicating an increase from $7.78 billion in 2025 to $8.88 billion in 2026, representing a compound annual growth rate (CAGR) of 14.1%. This historical growth has been driven by several factors, including restricted availability of genetic testing, dependence on traditional diagnostic approaches, heightened recognition of somatic mutations in cancer cases, enhanced infrastructure within hospitals and clinical laboratories, and growing financial commitments to research institutions.
The somatic genetic testing market is anticipated to experience rapid expansion over the coming years. By 2030, its value is projected to reach $14.92 billion, driven by a compound annual growth rate (CAGR) of 13.9%. This forecast growth is fueled by developments in next-generation sequencing (NGS) and multi-omics technologies, the broadening of both at-home and clinical sequencing options, a rise in precision medicine efforts, increased governmental support for genetic testing programs, and the incorporation of AI-driven analytics to interpret mutations. Among the key trends shaping this period are the growing preference for targeted gene panels to address cancer and rare diseases, the expanding application of NGS techniques, the advancement of personalized and precision oncology therapies, the wider availability of genetic testing kits for home use, and the utilization of multi-omics data to guide clinical decisions.
Download A Free Sample Report For Comprehensive Market Insights:
Somatic Genetic Testing Market Growth Drivers: What Factors Are Accelerating Expansion?
The rising occurrence of cancer is anticipated to drive expansion in the somatic genetic testing market moving forward. Cancer is defined as a set of disorders marked by the uncontrolled proliferation and spread of abnormal cells throughout the body. This growing cancer burden stems from lifestyle factors including unhealthy eating habits, tobacco use, lack of physical activity, and heavy alcohol intake. By identifying tumor-specific genetic mutations, somatic genetic testing supports cancer diagnosis, facilitating targeted and customized treatment strategies. It reduces the need for invasive procedures through the application of advanced technologies, enhancing diagnostic precision and patient outcomes. As an example, the Canadian Cancer Society, a national cancer organization based in Canada, reported in November 2023 that an estimated 239,100 Canadians are expected to receive a cancer diagnosis in 2023, with around 86,700 projected to succumb to the illness. Consequently, the escalating incidence of cancer is fueling growth in the somatic genetic testing market.
Somatic Genetic Testing Market Segmentation Trends And Revenue Drivers
The somatic genetic testing market covered in this report is segmented –
1) By Type: Targeted Gene Panels, Whole Exome Sequencing, Whole Genome Sequencing, Other Testing Methods
2) By Sample: Tissue-Based, Blood-Based, Bone Marrow Aspirates, Other Samples
3) By Technology: Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Microarray, Sanger Sequencing, Other Technologies
4) By Application: Cancer Diagnosis, Cardiovascular Disorders, Neurological Disorders, Other Applications
5) By End-User: Hospitals, Clinical Laboratories, Research Institutes, Other End-Users
Subsegments:
1) By Targeted Gene Panels: Oncology Panels, Neurology Panels, Cardiovascular Panels, Rare Disease Panels, Pharmacogenomics Panels
2) By Whole Exome Sequencing: Diagnostic Whole Exome Sequencing, Clinical Research Whole Exome Sequencing, Population-Based Whole Exome Sequencing
3) By Whole Genome Sequencing: Clinical Whole Genome Sequencing, Research Whole Genome Sequencing, De Novo Whole Genome Sequencing, Cancer Whole Genome Sequencing
4) By Other Testing Methods: Copy Number Variation Testing, Mitochondrial Deoxyribonucleic Acid (DNA) Testing, Ribonucleic Acid (RNA) Sequencing, Epigenetic Testing
Somatic Genetic Testing Market Trends: What Is Shaping Future Industry Growth?
Leading players within the somatic genetic testing sector are prioritizing the creation of sophisticated diagnostic tools, particularly liquid biopsy assays, to enhance precision, facilitate early diagnosis, and minimize dependence on invasive procedures. These liquid biopsy techniques involve non-invasive approaches that examine circulating tumor DNA (ctDNA) or various biomarkers present in blood specimens to identify cancer-associated genetic alterations. A notable example occurred in September 2024, when Strand Life Sciences, a genomics and bioinformatics firm based in India, introduced the Somatic Advantage 74 Liquid Biopsy (SA74 LB) test. This next-generation liquid biopsy assay is specifically tailored to identify circulating tumor DNA (ctDNA) extracted from blood samples. The SA74-LB represents an extensive next-generation sequencing (NGS)-based test capable of detecting somatic mutations across 74 crucial cancer-related genes. The test supports customized cancer treatment by recognizing actionable mutations, tracking therapeutic responses, and identifying minimal residual disease (MRD) without requiring conventional tissue biopsies. It furthers precision oncology by guiding targeted therapies and offering real-time monitoring of disease advancement or treatment resistance.
Somatic Genetic Testing Market Industry Leaders: Which Organizations Are Driving Competition?
Major companies operating in the somatic genetic testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., Exact Sciences Corp., ARUP Laboratories Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., MedGenome Labs Ltd., Caris Life Sciences Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Invivoscribe Inc., Centogene N.V., Circulogene Theranostics LLC.
Access The Complete Somatic Genetic Testing Market Report:
Somatic Genetic Testing Market Leading Geography: Which Region Generates The Most Revenue?
North America was the largest region in the somatic genetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the somatic genetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
